" class="no-js "lang="en-US"> Mergers & Aquisitions Archives - Page 3 of 12 - Medtech Alert
Friday, March 31, 2023

Sort by:


Top Post

ProPharma Acquires UK Based Digital Lab Consulting

ProPharma Group (ProPharma) the leading global provider of regulatory, clinical, and quality services for the […]

Focus-X Therapeutics Successfully Reached an Acquisition Agreement with Full-Life Technologies

Focus-X Therapeutics, a nuclide drug company that was invested in and incubated by Viva Biotech, […]

Rocket Pharmaceuticals Completes Acquisition of Renovacor

Rocket Pharmaceuticals, a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic […]

AstraZeneca to Acquire Neogene Therapeutics, Accelerating Ambition in Oncology Cell Therapy

AstraZeneca has announced an agreement to acquire Neogene Therapeutics, a global clinical-stage biotechnology company pioneering […]

Audax Private Equity Announces Acquisition of Medi-Weightloss, Inc.

Audax Private Equity announced the acquisition of Medi-Weightloss, a leading operator of science-based, physician-supervised weight-loss […]

Clarify Pharma Acquires Shares in Atai Life Sciences and Compass Pathways

Clarify Pharma, an investment vehicle specialising in biotech and life sciences companies seeking to prove […]

BioIVT Acquires Fidelis Research

BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, today […]

Concord Health Partners Adds Healthcare Private Equity Veteran Robert Schulz as Managing Director

Concord Health Partners (“Concord” or the “Firm”), a healthcare focused investment firm, today announced that […]

Gilead Sciences Completes Acquisition of MiroBio

GMiroBioilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction to […]

GENFIT Acquires Swiss Biotech Versantis for Over CHF105 Million

GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of […]

BioIVT Acquires XenoTech, a Leading Provider of Products and Services for Preclinical Testing of New Drug Candidates

BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, today […]

  1. Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis Read more
  2. NEC Establishes Subsidiaries in Europe for Strengthening Global AI Drug Development Business Read more
  3. Flare Therapeutics Further Strengthens Leadership Team with Key Executive Appointments and Promotions Read more
  4. Sensorion Appoints Khalil Barrage as Interim Chairman of the Board Read more
  5. Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China Read more